Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor

By Yagihashi Soroku  

Brain, Vol. 124, Iss. 12, 2001-12 ,pp. : 2448-2458

Oxford University Press

Access to resources Recommend Favorite

Nerve conduction velocity measurements reveal the functional deficit in ceramide galactosyl transferase-deficient (cgt-/-) mice

By Haupt W.F.   Stoffel W.  

Journal of the Neurological Sciences, Vol. 217, Iss. 1, 2004-01 ,pp. : 83-88

Elsevier

Access to resources Recommend Favorite

Taurine Counteracts Oxidative Stress and Nerve Growth Factor Deficit in Early Experimental Diabetic Neuropathy

By Obrosova I.G.   Fathallah L.   Stevens M.J.  

Experimental Neurology, Vol. 172, Iss. 1, 2001-11 ,pp. : 211-219

Elsevier

Access to resources Recommend Favorite

Prion Protein-Deficient Cells Show Altered Response to Oxidative Stress Due to Decreased SOD-1 Activity

By Brown D.R.   Schulz-Schaeffer W.J.   Schmidt B.   Kretzschmar H.A.  

Experimental Neurology, Vol. 146, Iss. 1, 1997-07 ,pp. : 104-112

Elsevier

Access to resources Recommend Favorite

The Absence of Synergism between the Effects of an Aldose Reductase Inhibitor, Epalrestat, and a Vasodilator, Cilostazol, on the Nerve Conduction Slowing and the Myelinated Fiber Atrophy in Streptozotocin-Induced Diabetic Rats

By Sasaki H.   Naka K.   Kishi Y.   Furuta M.   Sanke T.   Mukoyama M.   Nanjo K.  

Experimental Neurology, Vol. 146, Iss. 2, 1997-08 ,pp. : 466-470

Elsevier

Access to resources Recommend Favorite